Delivery Order SPE2DB24D2205-SPE2DB25FEFJP
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,786.46 on July 18, 2025, for the supply of Lyrica 50 mg capsules (90-count units). This contract was awarded on a firm fixed price basis with no set-aside designation, indicating competitive award conditions. The order is scheduled for completion by July 21, 2025, and is being funded through the Medical Supply Chain division of the Department of...
- The Defense Logistics Agency awarded a delivery order valued at $3,370.10 to AmerisourceBergen Drug Corp for the supply of Lyrica (pregabalin) 50 mg capsules in a 90-count quantity. This competitive award, issued on July 23, 2025, with a completion date of July 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,851.66 to AmerisourceBergen Drug Corp for the supply of Lyrica 200 mg capsules (90-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is for the delivery of Lyrica 300 mg capsules, with a completion date of February 9, 2024 and a potential value of $1,127.66. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 90-count bottles of the 300 mg Lyrica capsule medication. The $1,446.17 delivery order, which has a completion date of February 2, 2024, is not designated as a set-aside contract. Amerisourcebergen Drug Corp serves as a prime contractor to DLA Troop Support Medical, providing a wide range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Lyrica 300 mg capsules, a prescription medication. The contract has a ceiling value of $1,179.94 and a period of performance through April 8, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,877.62, is for the delivery of Lyrica 300 mg capsules. The contract is a firm fixed-price delivery order, with a period of performance through March 14, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order worth $4,848.21 by the Defense Logistics Agency (DLA) to provide Lyrica 75 mg capsules with a completion date of March 1, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Lyrica 100 mg capsules (90-count units) under a firm fixed price contract with a ceiling value of $4,066.23. The order was competitively awarded without a set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Lyrica is a neurological treatment medication commonly...
- This is a $2,088.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Lyrica 300 mg capsules, a medication used to treat certain types of nerve pain. The contract has an ultimate completion date of August 28, 2023 and was awarded on August 25, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFJPDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Lyrica 300 mg capsules (90-count). The contract carries a ceiling value of $1,179.94 under firm fixed pricing terms, with an ultimate completion date of July 25, 2025. This non-competitive delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award represents a child contract issued under a larger vehicle—specifically, the company's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This delivery order supports the Defense Health Agency's pharmaceutical supply requirements for military healthcare systems. Lyrica (pregabalin) is a neurological treatment commonly used in military medical facilities for pain management and neuropathic conditions. As a major pharmaceutical distributor with extensive federal procurement capabilities, AmerisourceBergen maintains a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The firm fixed pricing structure and rapid completion timeline reflect the operational urgency typical of military medical supply fulfillment through DLA's established prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/24/25 |